Invesco Biotechnology & Genome ETF
PBE
PBE
99 hedge funds and large institutions have $92.3M invested in Invesco Biotechnology & Genome ETF in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
99
Holders Change
-3
Holders Change %
-2.94%
% of All Funds
1.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
28
Reduced
24
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
EH
Equitable Holdings
New York
|
$227K |
2 |
UBS Group
Zurich,
Switzerland
|
$4.92M |
3 |
Bank of America
Charlotte,
North Carolina
|
$4.76M |
4 |
CW
CreativeOne Wealth
Overland Park,
Kansas
|
$2.26M |
5 |
Two Sigma Investments
New York
|
$0 |